Flu (Influenza) Vaccine Market Report

China Flu (Influenza) Vaccine Industry Market Research Report 2023-2029

  • POSTDATE：Oct 05, 2023
  • PAGES：220
  • REPORT CODE：GMM1827720
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Flu (Influenza) Vaccine industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Pfizer

    • Sinovac Biotech

    • Merck & Co

    • GlaxoSmithKline

    • AstraZeneca

    • Sanofi Pasteur

    • Emergent BioSolutions

    By Type:

    • Live Attenuated Virus Vaccines

    • Subunit Vaccines

    • Split Virus Vaccines

    • Whole Virus Vaccines

    By Application:

    • For Children (6 months to 3 years)

    • For Adults and Children over 3 years

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Flu (Influenza) Vaccine Market Overview 2018-2029

    • 1.1 China Flu (Influenza) Vaccine Industry Development Overview

    • 1.2 China Flu (Influenza) Vaccine Industry Development History

    • 1.3 China Flu (Influenza) Vaccine Industry Market Size (2018-2029)

    • 1.4 China Flu (Influenza) Vaccine Market Analysis by Type from Production Side

      • 1.4.1 China Flu (Influenza) Vaccine Production Volume, Production Value and Growth Rate of Live Attenuated Virus Vaccines (2018-2029)

      • 1.4.2 China Flu (Influenza) Vaccine Production Volume, Production Value and Growth Rate of Subunit Vaccines (2018-2029)

      • 1.4.3 China Flu (Influenza) Vaccine Production Volume, Production Value and Growth Rate of Split Virus Vaccines (2018-2029)

      • 1.4.4 China Flu (Influenza) Vaccine Production Volume, Production Value and Growth Rate of Whole Virus Vaccines (2018-2029)

    • 1.5 China Flu (Influenza) Vaccine Market Analysis by Application from Consumption End

      • 1.5.1 China Flu (Influenza) Vaccine Sales Volume, Sales Value and Growth Rate of For Children (6 months to 3 years) (2018-2029)

      • 1.5.2 China Flu (Influenza) Vaccine Sales Volume, Sales Value and Growth Rate of For Adults and Children over 3 years (2018-2029)

    • 1.6 China Flu (Influenza) Vaccine Market Analysis by Region

      • 1.6.1 North China Flu (Influenza) Vaccine Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Flu (Influenza) Vaccine Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Flu (Influenza) Vaccine Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Flu (Influenza) Vaccine Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Flu (Influenza) Vaccine Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Flu (Influenza) Vaccine Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Flu (Influenza) Vaccine Market Size and Growth Rate from 2018-2029

    Chapter 2 China Flu (Influenza) Vaccine Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Flu (Influenza) Vaccine Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Flu (Influenza) Vaccine Market Status and Competition Analysis in 2023

      • 2.2.3 China Flu (Influenza) Vaccine Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Flu (Influenza) Vaccine Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Flu (Influenza) Vaccine Industry Development

    Chapter 3 Flu (Influenza) VaccineIndustry Chain Analysis

    • 3.1 Flu (Influenza) Vaccine Industry Chain

    • 3.2 Flu (Influenza) Vaccine Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Flu (Influenza) Vaccine Market

    • 3.3 Flu (Influenza) Vaccine Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Flu (Influenza) Vaccine Market

    Chapter 4 China Flu (Influenza) Vaccine Market, by Type

    • 4.1 China Flu (Influenza) Vaccine Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Flu (Influenza) Vaccine Total Production Volume and Growth Rate from Production Side

    • 4.5 China Flu (Influenza) Vaccine Production Volume and Growth Rate, by Type

      • 4.5.1 China Flu (Influenza) Vaccine Production Volume and Growth Rate of Live Attenuated Virus Vaccines

      • 4.5.2 China Flu (Influenza) Vaccine Production Volume and Growth Rate of Subunit Vaccines

      • 4.5.3 China Flu (Influenza) Vaccine Production Volume and Growth Rate of Split Virus Vaccines

      • 4.5.4 China Flu (Influenza) Vaccine Production Volume and Growth Rate of Whole Virus Vaccines

    Chapter 5 China Flu (Influenza) Vaccine Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Flu (Influenza) Vaccine Total Market Size and Growth Rate from Consumption End

    • 5.5 China Flu (Influenza) Vaccine Market Size and Growth Rate, by Application

      • 5.5.1 China Flu (Influenza) Vaccine Market Size and Growth Rate of For Children (6 months to 3 years)

      • 5.5.2 China Flu (Influenza) Vaccine Market Size and Growth Rate of For Adults and Children over 3 years

    Chapter 6 China Flu (Influenza) Vaccine Market, by Region

    • 6.1 China Flu (Influenza) Vaccine Production Volume and Production Value, by Region

    • 6.2 China Flu (Influenza) Vaccine Sales Volume and Sales Value, by Region

    Chapter 7 North China Flu (Influenza) Vaccine Market Analysis

    • 7.1 North China Flu (Influenza) Vaccine Market, by Type

    • 7.2 North China Flu (Influenza) Vaccine Market, by Application

    Chapter 8 Central China Flu (Influenza) Vaccine Market Analysis

    • 8.1 Central China Flu (Influenza) Vaccine Market, by Type

    • 8.2 Central China Flu (Influenza) Vaccine Market, by Application

    Chapter 9 South China Flu (Influenza) Vaccine Market Analysis

    • 9.1 South China Flu (Influenza) Vaccine Market, by Type

    • 9.2 South China Flu (Influenza) Vaccine Market, by Application

    Chapter 10 East China Flu (Influenza) Vaccine Market Analysis

    • 10.1 East China Flu (Influenza) Vaccine Market, by Type

    • 10.2 East China Flu (Influenza) Vaccine Market, by Application

    Chapter 11 Northeast China Flu (Influenza) Vaccine Market Analysis

    • 11.1 Northeast China Flu (Influenza) Vaccine Market, by Type

    • 11.2 Northeast China Flu (Influenza) Vaccine Market, by Application

    Chapter 12 Southwest China Flu (Influenza) Vaccine Market Analysis

    • 12.1 Southwest China Flu (Influenza) Vaccine Market, by Type

    • 12.2 Southwest China Flu (Influenza) Vaccine Market, by Application

    Chapter 13 Northwest China Flu (Influenza) Vaccine Market Analysis

    • 13.1 Northwest China Flu (Influenza) Vaccine Market, by Type

    • 13.2 Northwest China Flu (Influenza) Vaccine Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Pfizer

        • 14.1.1 Pfizer Company Profile

        • 14.1.2 Pfizer Flu (Influenza) Vaccine Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Sinovac Biotech

        • 14.2.1 Sinovac Biotech Company Profile

        • 14.2.2 Sinovac Biotech Flu (Influenza) Vaccine Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Merck & Co

        • 14.3.1 Merck & Co Company Profile

        • 14.3.2 Merck & Co Flu (Influenza) Vaccine Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 GlaxoSmithKline

        • 14.4.1 GlaxoSmithKline Company Profile

        • 14.4.2 GlaxoSmithKline Flu (Influenza) Vaccine Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 AstraZeneca

        • 14.5.1 AstraZeneca Company Profile

        • 14.5.2 AstraZeneca Flu (Influenza) Vaccine Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Sanofi Pasteur

        • 14.6.1 Sanofi Pasteur Company Profile

        • 14.6.2 Sanofi Pasteur Flu (Influenza) Vaccine Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Emergent BioSolutions

        • 14.7.1 Emergent BioSolutions Company Profile

        • 14.7.2 Emergent BioSolutions Flu (Influenza) Vaccine Market Performance

        • 14.7.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Flu (Influenza) Vaccine Industry Research Conclusions

    • 15.2 Flu (Influenza) Vaccine Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Flu (Influenza) Vaccine Industry Market Size (2018-2029)

    • Figure China Flu (Influenza) Vaccine Production Volume, Production Value and Growth Rate of Live Attenuated Virus Vaccines (2018-2029)

    • Figure China Flu (Influenza) Vaccine Production Volume, Production Value and Growth Rate of Subunit Vaccines (2018-2029)

    • Figure China Flu (Influenza) Vaccine Production Volume, Production Value and Growth Rate of Split Virus Vaccines (2018-2029)

    • Figure China Flu (Influenza) Vaccine Production Volume, Production Value and Growth Rate of Whole Virus Vaccines (2018-2029)

    • Figure China Flu (Influenza) Vaccine Sales Volume, Sales Value and Growth Rate of For Children (6 months to 3 years) (2018-2029)

    • Figure China Flu (Influenza) Vaccine Sales Volume, Sales Value and Growth Rate of For Adults and Children over 3 years (2018-2029)

    • Figure North China Flu (Influenza) Vaccine Market Size and Growth Rate from 2018-2029

    • Figure Central China Flu (Influenza) Vaccine Market Size and Growth Rate from 2018-2029

    • Figure South China Flu (Influenza) Vaccine Market Size and Growth Rate from 2018-2029

    • Figure East China Flu (Influenza) Vaccine Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Flu (Influenza) Vaccine Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Flu (Influenza) Vaccine Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Flu (Influenza) Vaccine Market Size and Growth Rate from 2018-2029

    • Figure Flu (Influenza) Vaccine Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Flu (Influenza) Vaccine Market Share by Type in 2018

    • Figure China Flu (Influenza) Vaccine Market Share by Type in 2023

    • Figure China Flu (Influenza) Vaccine Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Flu (Influenza) Vaccine Production Volume and Growth Rate of Live Attenuated Virus Vaccines (2018-2023)

    • Figure China Flu (Influenza) Vaccine Production Volume and Growth Rate of Subunit Vaccines (2018-2023)

    • Figure China Flu (Influenza) Vaccine Production Volume and Growth Rate of Split Virus Vaccines (2018-2023)

    • Figure China Flu (Influenza) Vaccine Production Volume and Growth Rate of Whole Virus Vaccines (2018-2023)

    • Figure China Flu (Influenza) Vaccine Market Share by Application in 2018

    • Figure China Flu (Influenza) Vaccine Market Share by Application in 2023

    • Figure China Flu (Influenza) Vaccine Total Market Size and Growth Rate from Consumption End

    • Figure China Flu (Influenza) Vaccine Market Size and Growth Rate of For Children (6 months to 3 years) (2018-2023)

    • Figure China Flu (Influenza) Vaccine Market Size and Growth Rate of For Adults and Children over 3 years (2018-2023)

    • Table China Flu (Influenza) Vaccine Production Volume by Region (2018-2023)

    • Table China Flu (Influenza) Vaccine Production Volume Share by Region (2018-2023)

    • Figure China Flu (Influenza) Vaccine Production Volume Share by Region (2018-2023)

    • Table China Flu (Influenza) Vaccine Production Value by Region (2018-2023)

    • Table China Flu (Influenza) Vaccine Production Value Share by Region (2018-2023)

    • Figure China Flu (Influenza) Vaccine Production Value Share by Region (2018-2023)

    • Table China Flu (Influenza) Vaccine Sales Volume by Region (2018-2023)

    • Table China Flu (Influenza) Vaccine Sales Volume Share by Region (2018-2023)

    • Figure China Flu (Influenza) Vaccine Sales Volume Share by Region (2018-2023)

    • Table China Flu (Influenza) Vaccine Sales Value by Region (2018-2023)

    • Table China Flu (Influenza) Vaccine Sales Value Share by Region (2018-2023)

    • Figure China Flu (Influenza) Vaccine Sales Value Share by Region (2018-2023)

    • Table North China Flu (Influenza) Vaccine Production Volume by Type (2018-2023)

    • Table North China Flu (Influenza) Vaccine Production Volume Share by Type (2018-2023)

    • Figure North China Flu (Influenza) Vaccine Production Volume Share by Type (2018-2023)

    • Table North China Flu (Influenza) Vaccine Sales Volume by Application (2018-2023)

    • Table North China Flu (Influenza) Vaccine Sales Volume Share by Application (2018-2023)

    • Figure North China Flu (Influenza) Vaccine Sales Volume Share by Application (2018-2023)

    • Table Central China Flu (Influenza) Vaccine Production Volume by Type (2018-2023)

    • Table Central China Flu (Influenza) Vaccine Production Volume Share by Type (2018-2023)

    • Figure Central China Flu (Influenza) Vaccine Production Volume Share by Type (2018-2023)

    • Table Central China Flu (Influenza) Vaccine Sales Volume by Application (2018-2023)

    • Table Central China Flu (Influenza) Vaccine Sales Volume Share by Application (2018-2023)

    • Figure Central China Flu (Influenza) Vaccine Sales Volume Share by Application (2018-2023)

    • Table South China Flu (Influenza) Vaccine Production Volume by Type (2018-2023)

    • Table South China Flu (Influenza) Vaccine Production Volume Share by Type (2018-2023)

    • Figure South China Flu (Influenza) Vaccine Production Volume Share by Type (2018-2023)

    • Table South China Flu (Influenza) Vaccine Sales Volume by Application (2018-2023)

    • Table South China Flu (Influenza) Vaccine Sales Volume Share by Application (2018-2023)

    • Figure South China Flu (Influenza) Vaccine Sales Volume Share by Application (2018-2023)

    • Table East China Flu (Influenza) Vaccine Production Volume by Type (2018-2023)

    • Table East China Flu (Influenza) Vaccine Production Volume Share by Type (2018-2023)

    • Figure East China Flu (Influenza) Vaccine Production Volume Share by Type (2018-2023)

    • Table East China Flu (Influenza) Vaccine Sales Volume by Application (2018-2023)

    • Table East China Flu (Influenza) Vaccine Sales Volume Share by Application (2018-2023)

    • Figure East China Flu (Influenza) Vaccine Sales Volume Share by Application (2018-2023)

    • Table Northeast China Flu (Influenza) Vaccine Production Volume by Type (2018-2023)

    • Table Northeast China Flu (Influenza) Vaccine Production Volume Share by Type (2018-2023)

    • Figure Northeast China Flu (Influenza) Vaccine Production Volume Share by Type (2018-2023)

    • Table Northeast China Flu (Influenza) Vaccine Sales Volume by Application (2018-2023)

    • Table Northeast China Flu (Influenza) Vaccine Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Flu (Influenza) Vaccine Sales Volume Share by Application (2018-2023)

    • Table Southwest China Flu (Influenza) Vaccine Production Volume by Type (2018-2023)

    • Table Southwest China Flu (Influenza) Vaccine Production Volume Share by Type (2018-2023)

    • Figure Southwest China Flu (Influenza) Vaccine Production Volume Share by Type (2018-2023)

    • Table Southwest China Flu (Influenza) Vaccine Sales Volume by Application (2018-2023)

    • Table Southwest China Flu (Influenza) Vaccine Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Flu (Influenza) Vaccine Sales Volume Share by Application (2018-2023)

    • Table Northwest China Flu (Influenza) Vaccine Production Volume by Type (2018-2023)

    • Table Northwest China Flu (Influenza) Vaccine Production Volume Share by Type (2018-2023)

    • Figure Northwest China Flu (Influenza) Vaccine Production Volume Share by Type (2018-2023)

    • Table Northwest China Flu (Influenza) Vaccine Sales Volume by Application (2018-2023)

    • Table Northwest China Flu (Influenza) Vaccine Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Flu (Influenza) Vaccine Sales Volume Share by Application (2018-2023)

    • Table Pfizer Company Profile

    • Table Pfizer Flu (Influenza) Vaccine Revenue, Price and Gross (2018-2023)

    • Table Sinovac Biotech Company Profile

    • Table Sinovac Biotech Flu (Influenza) Vaccine Revenue, Price and Gross (2018-2023)

    • Table Merck & Co Company Profile

    • Table Merck & Co Flu (Influenza) Vaccine Revenue, Price and Gross (2018-2023)

    • Table GlaxoSmithKline Company Profile

    • Table GlaxoSmithKline Flu (Influenza) Vaccine Revenue, Price and Gross (2018-2023)

    • Table AstraZeneca Company Profile

    • Table AstraZeneca Flu (Influenza) Vaccine Revenue, Price and Gross (2018-2023)

    • Table Sanofi Pasteur Company Profile

    • Table Sanofi Pasteur Flu (Influenza) Vaccine Revenue, Price and Gross (2018-2023)

    • Table Emergent BioSolutions Company Profile

    • Table Emergent BioSolutions Flu (Influenza) Vaccine Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US